Farallon Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Hold |
26,000
| – | – | ﹤0.01% | 94 |
|
|
2025
Q1 | $407K | Hold |
26,000
| – | – | ﹤0.01% | 91 |
|
|
2024
Q4 | $362K | Hold |
26,000
| – | – | ﹤0.01% | 96 |
|
|
2024
Q3 | $242K | Hold |
26,000
| – | – | ﹤0.01% | 124 |
|
|
2024
Q2 | $242K | Sell |
26,000
-1,754,000
| -99% | -$16.3M | ﹤0.01% | 119 |
|
|
2024
Q1 | $17.6M | Buy |
+1,780,000
| New | +$17.6M | 0.08% | 74 |
|